Oleuropein inhibits the proliferation and invasion of glioma cells via suppression of the AKT signaling pathway

Oncology Reports

Volumn 36, Issue 4, 2016, Pages 2009-2016

  Liu, Ming ^a   Wang, Jian ^a,b   Huang, Bin ^a   Chen, Anjing ^a   Li, Xingang ^a  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

AKT; Antitumor; Glioma; Oleuropein

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GELATINASE A; GELATINASE B; OLEUROPEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; ANTINEOPLASTIC AGENT; IRIDOID;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME REPRESSION; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; BRAIN TUMOR; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; GLIOMA; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; FLOW CYTOMETRY; GLIOMA; HUMANS; IRIDOIDS; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84985011714     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2016.4978     Document Type: Article

References (47)

1. Fisher PG and Buffler PA: Malignant gliomas in 2005: Where to GO from here? JAMA 293:615-617, 2005.
2. Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K and Delattre JY: Primary brain tumours in adults. Lancet 379:1984-1996, 2012.
3. Rock K, McArdle O, Forde P, Dunne M, Fitzpatrick D, O'Neill B and Faul C: A clinical review of treatment outcomes in glioblastoma multiforme - the validation in a non-trial population of the results of a randomised Phase III clinical trial: Has a more radical approach improved survival. Br J Radiol 85:729-733, 2012.
4. Coni E, Di Benedetto R, Di Pasquale M, Masella R, Modesti D, Mattei R and Carlini EA: Protective effect of oleuropein, an olive oil biophenol, on low density lipoprotein oxidizability in rabbits. Lipids 35:45-54, 2000.
5. Visioli F, Caruso D, Galli C, Viappiani S, Galli G and Sala A: Olive oils rich in natural catecholic phenols decrease isoprostane excretion in humans. Biochem Biophys Res Commun 278:797-799, 2000.
6. Aziz NH, Farag SE, Mousa LA and Abo-Zaid MA: Comparative antibacterial and antifungal effects of some phenolic compounds. Microbios 93:43-54, 1998.
7. Bisignano G, Tomaino A, Lo Cascio R, Crisafi G, Uccella N and Saija A: On the in-vitro antimicrobial activity of oleuropein and hydroxytyrosol. J Pharm Pharmacol 51:971-974, 1999.
8. Micol V, Caturla N, Pérez-Fons L, Más V, Pérez L and Estepa A: The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV). Antiviral Res 66:129-136, 2005.
9. Lee-Huang S, Zhang L, Huang PL, Chang YT and Huang PL: Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment. Biochem Biophys Res Commun 307:1029-1037, 2003.
10. Bazoti FN, Bergquist J, Markides KE and Tsarbopoulos A: Noncovalent interaction between amyloid-beta-peptide (1-40) and oleuropein studied by electrospray ionization mass spectrometry. J Am Soc Mass Spectrom 17:568-575, 2006.
11. Mijatovic SA, Timotijevic GS, Miljkovic DM, Radovic JM, Maksimovic-Ivanic DD, Dekanski DP and Stosic-Grujicic SD: Multiple antimelanoma potential of dry olive leaf extract. Int J Cancer 128:1955-1965, 2011.
12. Fares R, Bazzi S, Baydoun SE and Abdel-Massih RM: The antioxidant and anti-proliferative activity of the Lebanese Olea europaea extract. Plant Foods Hum Nutr 66:58-63, 2011.
13. Corona G, Deiana M, Incani A, Vauzour D, Dessì MA and Spencer JP: Inhibition of p38/CREB phosphorylation and COX-2 expression by olive oil polyphenols underlies their anti-proliferative effects. Biochem Biophys Res Commun 362:606-611, 2007.
14. Han J, Talorete TP, Yamada P and Isoda H: Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells. Cytotechnology 59:45-53, 2009.
15. Acquaviva R, Di Giacomo C, Sorrenti V, Galvano F, Santangelo R, Cardile V, Gangia S, D'Orazio N, Abraham NG and Vanella L: Antiproliferative effect of oleuropein in prostate cell lines. Int J Oncol 41:31-38, 2012.
16. Chan SL and Yu VC: Proteins of the bcl-2 family in apoptosis signalling: From mechanistic insights to therapeutic opportunities. Clin Exp Pharmacol Physiol 31:119-128, 2004.
17. Nakano A, Tani E, Miyazaki K, Yamamoto Y and Furuyama J: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83:298-307, 1995.
18. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619, 1993.
19. Marzo I, Brenner C, Zamzami N, Jürgensmeier JM, Susin SA, Vieira HL, Prévost MC, Xie Z, Matsuyama S, Reed JC, et al: Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281:2027-2031, 1998.
20. Gialeli C, Theocharis AD and Karamanos NK: Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278:16-27, 2011.
21. Kettenmann H, Hanisch UK, Noda M and Verkhratsky A: Physiology of microglia. Physiol Rev 91:461-553, 2011.
22. Opferman JT and Korsmeyer SJ: Apoptosis in the development and maintenance of the immune system. Nat Immunol 4:410-415, 2003.
23. Vaux DL, Cory S and Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442, 1988.
24. Strasser A, Harris AW, Bath ML and Cory S: Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348:331-333, 1990.
25. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275:1129-1132, 1997.
26. Danial NN: BCL-2 family proteins: Critical checkpoints of apoptotic cell death. Clin Cancer Res 13:7254-7263, 2007.
27. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, et al: Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441-446, 1999.
28. Du C, Fang M, Li Y, Li L and Wang X: Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33-42, 2000.
29. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ and Vaux DL: Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102:43-53, 2000.
30. Li LY, Luo X and Wang X: Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412:95-99, 2001.
31. Baffy G, Miyashita T, Williamson JR and Reed JC: Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem 268:6511-6519, 1993.
32. Hennet T, Bertoni G, Richter C and Peterhans E: Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res 53:1456-1460, 1993.
33. Lam M, Dubyak G, Chen L, Nuñez G, Miesfeld RL and Distelhorst CW: Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc Natl Acad Sci USA 91:6569-6573, 1994.
34. Zhang N, Wang X, Huo Q, Li X, Wang H, Schneider P, Hu G and Yang Q: The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) in breast cancer. J Biol Chem 288:9396-9407, 2013.
35. Crompton M: Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. Curr Opin Cell Biol 12:414-419, 2000.
36. Habibovic S, Hrgovic Z, Bukvic I and Hrgovic I: Molecular mechanisms in apoptosis. Med Arh 54:33-40, 2000 (In Croatian).
37. Antonsson B: Bax and other pro-apoptotic Bcl-2 family 'killer-proteins? and their victim the mitochondrion. Cell Tissue Res 306:347-361, 2001.
38. Himelstein BP, Lee EJ, Sato H, Seiki M and Muschel RJ: Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: Involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat. Clin Exp Metastasis 16:169-177, 1998.
39. Hu Y and Ivashkiv LB: Costimulation of chemokine receptor signaling by matrix metalloproteinase-9 mediates enhanced migration of IFN-alpha dendritic cells. J Immunol 176:6022-6033, 2006.
40. Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N and Ross JS: Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res 7:3113-3119, 2001.
41. Wang F, Zhang P, Yang L, Yu X, Ye X, Yang J, Qian C, Zhang X, Cui YH and Bian XW: Activation of toll-like receptor 2 promotes invasion by upregulating MMPs in glioma stem cells. Am J Transl Res 7:607-615, 2015.
42. Zhang Z, Lv J, Lei X, Li S, Zhang Y, Meng L, Xue R and Li Z: Baicalein reduces the invasion of glioma cells via reducing the activity of p38 signaling pathway. PLoS One 9:e90318, 2014.
43. Fresno Vara JA, Casado E, De Castro J, Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30:193-204, 2004.
44. Fang Z, Tang Y, Jiao W, Xing Z, Guo Z, Wang W, Shi B, Xu Z and Liu Z: Nitidine chloride inhibits renal cancer cell metastasis via suppressing AKT signaling pathway. Food Chem Toxicol 60:246-251, 2013.
45. Vier J, Groth M, Sochalska M and Kirschnek S: The anti-apoptotic Bcl-2 family protein A1/Bfl-1 regulates neutrophil survival and homeostasis and is controlled via PI3K and JAK/STAT signaling. Cell Death Dis 7:e2103, 2016.
46. Morgensztern D and McLeod HL: PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer Drugs 16:797-803, 2005.
47. Carrera-González MP, Ramírez-Expósito MJ, Mayas MD and Martínez-Martos JM: Protective role of oleuropein and its metabolite hydroxytyrosol on cancer. Trends Food Sci Technol 31:92-99, 2013.